Source:http://linkedlifedata.com/resource/pubmed/id/19324223
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-3-27
|
pubmed:abstractText |
We compared substrate reduction in patients with lysosomal storage disorder treated with hematopoietic stem cell transplant and found that it was significantly reduced compared with patients treated with pharmacological enzyme replacement therapy. These data might support the wider application of hematopoietic stem cell transplant in the treatment of lysosomal storage disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1097-6833
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
154
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
609-11
|
pubmed:meshHeading |
pubmed-meshheading:19324223-Biological Markers,
pubmed-meshheading:19324223-Chondroitin Sulfates,
pubmed-meshheading:19324223-Dermatan Sulfate,
pubmed-meshheading:19324223-Enzymes,
pubmed-meshheading:19324223-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19324223-Humans,
pubmed-meshheading:19324223-Mucopolysaccharidosis I,
pubmed-meshheading:19324223-Mucopolysaccharidosis II,
pubmed-meshheading:19324223-Mucopolysaccharidosis VI
|
pubmed:year |
2009
|
pubmed:articleTitle |
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
|
pubmed:affiliation |
Department of Haematology and BMT, Royal Manchester Children's Hospital, Manchester, United Kingdom. robert.wynn@cmmc.nhs.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|